High Note Wealth’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$6.08K Hold
31
﹤0.01% 478
2025
Q4
$5.38K Hold
31
﹤0.01% 470
2025
Q3
$5.91K Hold
31
﹤0.01% 401
2025
Q2
$5.57K Hold
31
﹤0.01% 385
2025
Q1
$5.25K Hold
31
﹤0.01% 393
2024
Q4
$4.68K Buy
+31
New +$4.82K ﹤0.01% 462

Other funds holding DGX

High Note Wealth's DGX Position: Q1 2026 in Review

High Note Wealth held its Quest Diagnostics (DGX) position steady in Q1 2026 at 31 shares worth $6.08K. The position accounts for ﹤0.01% of the portfolio, ranked #478.

High Note Wealth first reported a position in DGX in Q4 2024 and has held it in 6 quarters since. 1,064 funds tracked by Wall St. Rank hold DGX as of Q1 2026.

  • High Note Wealth held 31 shares of Quest Diagnostics worth $6.08K as of Q1 2026.
  • High Note Wealth left its Quest Diagnostics share count unchanged in Q1 2026.
  • Quest Diagnostics made up ﹤0.01% of High Note Wealth's portfolio in Q1 2026, its #478 holding.
  • High Note Wealth first reported a position in Quest Diagnostics in Q4 2024 and has held it in 6 quarters since.
  • 1,064 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2026.

Based on High Note Wealth's 13F filing for Q1 2026, filed 11 May 2026.